Skip to content
Friends of Cancer Research
About
About Friends
Team
Board of Directors
Financials & Policies
Impact Reports
Scientific Reports
Projects
View All Projects
Research Partnerships
ctMoniTR Project
Digital PATH Project
HRD Harmonization Project
Real-World Evidence Portfolio
Policy Initiatives
Cell & Gene Therapies
Clinical Trial Eligibility Criteria
Lung-MAP
Tolerability & Dosing
Analyses
Drug Development Dashboards
About Breakthrough Therapies
Search Breakthrough Therapies
Events
Upcoming Events
Past Events
Annual Meeting
Cancer Leadership Awards
News
In The News
Blog: Engaging Innovation
Press Releases
Advocacy Newsletter
Publications
View All Publications
Peer Reviewed Publications
Scientific Reports
White Papers
Posters
Advocacy
Patients and Advocates
ProgressforPatients.org
Project TEACH
Advisory Advocates
Donate
Search
Navigation Toggle
About
About Friends
Team
Board of Directors
Financials & Policies
Impact Reports
Scientific Reports
Projects
View All Projects
Research Partnerships
ctMoniTR Project
Digital PATH Project
HRD Harmonization Project
Real-World Evidence Portfolio
Policy Initiatives
Cell & Gene Therapies
Clinical Trial Eligibility Criteria
Lung-MAP
Tolerability & Dosing
Analyses
Drug Development Dashboards
About Breakthrough Therapies
Search Breakthrough Therapies
Events
Upcoming Events
Past Events
Annual Meeting
Cancer Leadership Awards
News
In The News
Blog: Engaging Innovation
Press Releases
Advocacy Newsletter
Publications
View All Publications
Peer Reviewed Publications
Scientific Reports
White Papers
Posters
Advocacy
Patients and Advocates
ProgressforPatients.org
Project TEACH
Advisory Advocates
Donate
twitter
linkedin
youtube
Keyword search
Submit
Search
Close
Market Exclusivity
Market Exclusivity
Defined under
Generic Drugs
.
More Cancer and Drug Development Terms
